198 related articles for article (PubMed ID: 23194469)
1. Prevalence of thyrotoxicosis, antithyroid medication use, and complications among pregnant women in the United States.
Korelitz JJ; McNally DL; Masters MN; Li SX; Xu Y; Rivkees SA
Thyroid; 2013 Jun; 23(6):758-65. PubMed ID: 23194469
[TBL] [Abstract][Full Text] [Related]
2. Gestational thyrotoxicosis, antithyroid drug use and neonatal outcomes within an integrated healthcare delivery system.
Lo JC; Rivkees SA; Chandra M; Gonzalez JR; Korelitz JJ; Kuzniewicz MW
Thyroid; 2015 Jun; 25(6):698-705. PubMed ID: 25747892
[TBL] [Abstract][Full Text] [Related]
3. Treatment of graves' disease with antithyroid drugs in the first trimester of pregnancy and the prevalence of congenital malformation.
Yoshihara A; Noh J; Yamaguchi T; Ohye H; Sato S; Sekiya K; Kosuga Y; Suzuki M; Matsumoto M; Kunii Y; Watanabe N; Mukasa K; Ito K; Ito K
J Clin Endocrinol Metab; 2012 Jul; 97(7):2396-403. PubMed ID: 22547422
[TBL] [Abstract][Full Text] [Related]
4. Birth defects after early pregnancy use of antithyroid drugs: a Danish nationwide study.
Andersen SL; Olsen J; Wu CS; Laurberg P
J Clin Endocrinol Metab; 2013 Nov; 98(11):4373-81. PubMed ID: 24151287
[TBL] [Abstract][Full Text] [Related]
5. Risk of adverse perinatal outcomes with antithyroid treatment during pregnancy: a nationwide population-based study.
Chen CH; Xirasagar S; Lin CC; Wang LH; Kou YR; Lin HC
BJOG; 2011 Oct; 118(11):1365-73. PubMed ID: 21624036
[TBL] [Abstract][Full Text] [Related]
6. Antithyroid drug therapy in pregnancy and risk of congenital anomalies: Systematic review and meta-analysis.
Agrawal M; Lewis S; Premawardhana L; Dayan CM; Taylor PN; Okosieme OE
Clin Endocrinol (Oxf); 2022 Jun; 96(6):857-868. PubMed ID: 34845757
[TBL] [Abstract][Full Text] [Related]
7. Pregnancy outcome in women treated with methimazole or propylthiouracil during pregnancy.
Gianetti E; Russo L; Orlandi F; Chiovato L; Giusti M; Benvenga S; Moleti M; Vermiglio F; Macchia PE; Vitale M; Regalbuto C; Centanni M; Martino E; Vitti P; Tonacchera M
J Endocrinol Invest; 2015 Sep; 38(9):977-85. PubMed ID: 25840794
[TBL] [Abstract][Full Text] [Related]
8. Effects of methimazole and propylthiouracil exposure during pregnancy on the risk of neonatal congenital malformations: A meta-analysis.
Song R; Lin H; Chen Y; Zhang X; Feng W
PLoS One; 2017; 12(7):e0180108. PubMed ID: 28671971
[TBL] [Abstract][Full Text] [Related]
9. The safety of methimazole and propylthiouracil in pregnancy: a systematic review.
Hackmon R; Blichowski M; Koren G
J Obstet Gynaecol Can; 2012 Nov; 34(11):1077-1086. PubMed ID: 23231846
[TBL] [Abstract][Full Text] [Related]
10. Birth defects after use of antithyroid drugs in early pregnancy: a Swedish nationwide study.
Andersen SL; Lönn S; Vestergaard P; Törring O
Eur J Endocrinol; 2017 Oct; 177(4):369-378. PubMed ID: 28780518
[TBL] [Abstract][Full Text] [Related]
11. Antithyroid drug-related hepatotoxicity in hyperthyroidism patients: a population-based cohort study.
Wang MT; Lee WJ; Huang TY; Chu CL; Hsieh CH
Br J Clin Pharmacol; 2014 Sep; 78(3):619-29. PubMed ID: 25279406
[TBL] [Abstract][Full Text] [Related]
12. Maternal Thyroid Function, Use of Antithyroid Drugs in Early Pregnancy, and Birth Defects.
Andersen SL; Knøsgaard L; Olsen J; Vestergaard P; Andersen S
J Clin Endocrinol Metab; 2019 Dec; 104(12):6040-6048. PubMed ID: 31408173
[TBL] [Abstract][Full Text] [Related]
13. Antithyroid drug use during pregnancy and the risk of birth defects in offspring: systematic review and meta-analysis of observational studies with methodological considerations.
Morales DR; Fonkwen L; Nordeng HME
Br J Clin Pharmacol; 2021 Oct; 87(10):3890-3900. PubMed ID: 33783857
[TBL] [Abstract][Full Text] [Related]
14. Therapy of endocrine disease: antithyroid drug use in early pregnancy and birth defects: time windows of relative safety and high risk?
Laurberg P; Andersen SL
Eur J Endocrinol; 2014 Jul; 171(1):R13-20. PubMed ID: 24662319
[TBL] [Abstract][Full Text] [Related]
15. Incidence of and Risk Factors for Neonatal Hypothyroidism Among Women with Graves' Disease Treated with Antithyroid Drugs Until Delivery.
Yoshihara A; Noh JY; Inoue K; Watanabe N; Fukushita M; Matsumoto M; Suzuki N; Suzuki A; Kinoshita A; Yoshimura R; Aida A; Imai H; Hiruma S; Sugino K; Ito K
Thyroid; 2023 Mar; 33(3):373-379. PubMed ID: 36680759
[No Abstract] [Full Text] [Related]
16. A Disproportionality Analysis of the Adverse Effect Profiles of Methimazole and Propylthiouracil in Patients with Hyperthyroidism Using the Japanese Adverse Drug Event Report Database.
Arai M; Tsuno T; Konishi H; Nishiyama K; Terauchi Y; Inoue R; Shirakawa J
Thyroid; 2023 Jul; 33(7):804-816. PubMed ID: 37130038
[No Abstract] [Full Text] [Related]
17. Pharmacological treatment of hyperthyroidism during lactation: review of the literature and novel data.
Karras S; Tzotzas T; Kaltsas T; Krassas GE
Pediatr Endocrinol Rev; 2010 Sep; 8(1):25-33. PubMed ID: 21037541
[TBL] [Abstract][Full Text] [Related]
18. Choanal atresia associated with prenatal methimazole exposure: three new patients.
Barbero P; Ricagni C; Mercado G; Bronberg R; Torrado M
Am J Med Genet A; 2004 Aug; 129A(1):83-6. PubMed ID: 15266622
[TBL] [Abstract][Full Text] [Related]
19. Risk of congenital anomalies associated with antithyroid treatment during pregnancy: a meta-analysis.
Li X; Liu GY; Ma JL; Zhou L
Clinics (Sao Paulo); 2015 Jun; 70(6):453-9. PubMed ID: 26106966
[TBL] [Abstract][Full Text] [Related]
20. Analysis of Antithyroid Drug-Induced Severe Liver Injury in 18,558 Newly Diagnosed Patients with Graves' Disease in Japan.
Suzuki N; Noh JY; Hiruma M; Kawaguchi A; Morisaki M; Ohye H; Suzuki M; Matsumoto M; Kunii Y; Iwaku K; Yoshihara A; Watanabe N; Sugino K; Ito K
Thyroid; 2019 Oct; 29(10):1390-1398. PubMed ID: 31573408
[No Abstract] [Full Text] [Related]
[Next] [New Search]
